Phase I study of oral sonidegib (LDE225) in pediatric brain and solid tumors and a phase II study in children and adults with relapsed medulloblastoma
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Phase I study of oral sonidegib (LDE225) in pediatric brain and solid tumors and a phase II study in children and adults with relapsed medulloblastoma
Authors
Keywords
-
Journal
NEURO-ONCOLOGY
Volume 19, Issue 11, Pages 1542-1552
Publisher
Oxford University Press (OUP)
Online
2017-06-08
DOI
10.1093/neuonc/nox109
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Risk stratification of childhood medulloblastoma in the molecular era: the current consensus
- (2016) Vijay Ramaswamy et al. ACTA NEUROPATHOLOGICA
- Relapse patterns and outcome after relapse in standard risk medulloblastoma: a report from the HIT-SIOP-PNET4 study
- (2016) Magnus Sabel et al. JOURNAL OF NEURO-ONCOLOGY
- Vismodegib Exerts Targeted Efficacy Against Recurrent Sonic Hedgehog–Subgroup Medulloblastoma: Results From Phase II Pediatric Brain Tumor Consortium Studies PBTC-025B and PBTC-032
- (2015) Giles W. Robinson et al. JOURNAL OF CLINICAL ONCOLOGY
- Pilot Study of Intensive Chemotherapy With Peripheral Hematopoietic Cell Support for Children Less Than 3 Years of Age With Malignant Brain Tumors, the CCG-99703 Phase I/II Study. A Report From the Children's Oncology Group
- (2015) Bruce H. Cohen et al. PEDIATRIC NEUROLOGY
- Genome Sequencing of SHH Medulloblastoma Predicts Genotype-Related Response to Smoothened Inhibition
- (2014) Marcel Kool et al. CANCER CELL
- A Five-Gene Hedgehog Signature Developed as a Patient Preselection Tool for Hedgehog Inhibitor Therapy in Medulloblastoma
- (2014) Yaping Shou et al. CLINICAL CANCER RESEARCH
- A Phase I, Multicenter, Open-Label, First-in-Human, Dose-Escalation Study of the Oral Smoothened Inhibitor Sonidegib (LDE225) in Patients with Advanced Solid Tumors
- (2014) J. Rodon et al. CLINICAL CANCER RESEARCH
- Treatment of recurrent primitive neuroectodermal tumors (PNET) in children and adolescents with high-dose chemotherapy (HDC) and stem cell support: results of the HITREZ 97 multicentre trial
- (2014) U. Bode et al. JOURNAL OF NEURO-ONCOLOGY
- Phase I Study of the Hedgehog Pathway Inhibitor IPI-926 in Adult Patients with Solid Tumors
- (2013) A. Jimeno et al. CLINICAL CANCER RESEARCH
- Phase I Study of Vismodegib in Children with Recurrent or Refractory Medulloblastoma: A Pediatric Brain Tumor Consortium Study
- (2013) A. Gajjar et al. CLINICAL CANCER RESEARCH
- Processing Speed, Attention, and Working Memory After Treatment for Medulloblastoma: An International, Prospective, and Longitudinal Study
- (2013) Shawna L. Palmer et al. JOURNAL OF CLINICAL ONCOLOGY
- Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis
- (2013) Vijay Ramaswamy et al. LANCET ONCOLOGY
- Outcome of Children With Metastatic Medulloblastoma Treated With Carboplatin During Craniospinal Radiotherapy: A Children's Oncology Group Phase I/II Study
- (2012) Regina I. Jakacki et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular subgroups of medulloblastoma: the current consensus
- (2011) Michael D. Taylor et al. ACTA NEUROPATHOLOGICA
- Phase I Trial of Hedgehog Pathway Inhibitor Vismodegib (GDC-0449) in Patients with Refractory, Locally Advanced or Metastatic Solid Tumors
- (2011) P. M. LoRusso et al. CLINICAL CANCER RESEARCH
- Heterogeneity of familial medulloblastoma and contribution of germline PTCH1 and SUFU mutations to sporadic medulloblastoma
- (2010) Ingrid Slade et al. Familial Cancer
- Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
- (2010) Patrick Y. Wen et al. JOURNAL OF CLINICAL ONCOLOGY
- Medulloblastoma Comprises Four Distinct Molecular Variants
- (2010) Paul A. Northcott et al. JOURNAL OF CLINICAL ONCOLOGY
- Ocular anomalies and holoprosencephaly in a lamb
- (2010) Caroline J. Zeiss et al. VETERINARY OPHTHALMOLOGY
- Discovery of NVP-LDE225, a Potent and Selective Smoothened Antagonist
- (2010) Shifeng Pan et al. ACS Medicinal Chemistry Letters
- Mechanisms of Hedgehog pathway activation in cancer and implications for therapy
- (2009) Suzie J. Scales et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Transient Inhibition of the Hedgehog Pathway in Young Mice Causes Permanent Defects in Bone Structure
- (2008) Hiromichi Kimura et al. CANCER CELL
- Acquisition of Granule Neuron Precursor Identity Is a Critical Determinant of Progenitor Cell Competence to Form Shh-Induced Medulloblastoma
- (2008) Ulrich Schüller et al. CANCER CELL
- Critical aspects of the Bayesian approach to phase I cancer trials
- (2008) Beat Neuenschwander et al. STATISTICS IN MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search